Clinical trial
Effects of Zometa and Physical Activity on Bone Density in Women Receiving…
NCT00202059 · HealthPartners Institute, Other · Completed
Key facts
| NCT number | NCT00202059 |
|---|---|
| Title | Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer |
| Official title | The Effects of Zoledronic Acid (Zometa) and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer |
| Lead sponsor | HealthPartners Institute, Other |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Behavioral, Drug |
| Interventions | Zoledronic acid, Physical activity intervention |
| Enrollment | 72 |
| Start date | Jun 1, 2003 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Dec 16, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: